Veronika Bouskova | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Dr. Veronika Bouskova | Molecular Biology | Best Researcher Award

Young scientist from Biomedical Centre in Pilsen, Czech Republic.

Dr. Veronika Boušková (née Brynychová) is a distinguished Czech researcher in the field of molecular biology and pharmacogenomics, with a particular focus on breast cancer biology and genetic variability. Her career combines academic research, laboratory-based investigation, and mentoring of young scientists. With a Ph.D. from the Third Faculty of Medicine at Charles University and over a decade of experience at premier research institutions like the Biomedical Center of the Faculty of Medicine in Pilsen and the National Institute of Public Health in Prague, she has established herself as a leading expert in transcriptomic analysis, caspase signaling, and the clinical implications of genetic variants in cancer prognosis and treatment. Dr. Boušková has authored or co-authored numerous articles published in high-impact journals and holds an impressive h-index of 13. Her research is notable for its integrative approach, combining molecular, cellular, and genetic data to better understand cancer progression and therapy resistance. She is also actively involved in academic education and mentoring, guiding the next generation of scientists. Her ability to conduct interdisciplinary research and her contributions to clinical and translational oncology make her a strong candidate for recognition through research awards.

Professional Profile

Education

Dr. Boušková has pursued a rigorous and interdisciplinary educational path rooted in biological sciences. She earned her Bachelor’s degree in Biology from the Faculty of Science at Charles University in 2008, followed by a Master’s degree in Biology, which she completed in 2010 through a collaborative program involving the Department of Anthropology and Human Genetics and the Institute of Archaeology at the Academy of Sciences. Her education culminated in a Ph.D. in Molecular and Cell Biology, Genetics, and Virology from the Third Faculty of Medicine, Charles University, which she pursued from 2010 to 2018. Her doctoral studies provided her with a comprehensive understanding of molecular and cellular mechanisms involved in human diseases, with a particular emphasis on cancer genetics and apoptosis. This strong educational foundation, grounded in both human genetics and molecular medicine, has enabled her to bridge basic scientific research with clinical applications. Additionally, Dr. Boušková’s involvement in interdisciplinary and international study programs reflects her commitment to continuous academic and professional growth, and has enriched her scientific perspective with cultural and methodological diversity.

Professional Experience

Dr. Boušková’s professional journey reflects her long-standing commitment to biomedical research and her evolving expertise in oncology-related molecular genetics. Since 2013, she has served as a Junior Researcher at the Biomedical Center, Faculty of Medicine in Pilsen, Charles University, where she works in the Laboratory of Pharmacogenomics. Simultaneously, she has maintained a research position at the National Institute of Public Health in Prague since 2010. Her work across both institutions focuses on investigating genetic variability, apoptosis-related genes, and microRNA expression in cancer patients, especially those with breast carcinoma. Between August 2019 and January 2022, she was on maternity leave, after which she resumed her scientific endeavors. Dr. Boušková has also been actively involved in teaching since 2015, conducting practical courses in biochemical laboratory techniques at the Faculty of Science, Charles University. She has mentored and consulted graduate students, contributing to their academic development and research projects. Her dual roles in research and education reflect a well-rounded professional profile combining laboratory excellence, mentorship, and scientific publication. Her sustained engagement in public health-oriented molecular research illustrates her commitment to improving healthcare outcomes through advanced biomedical science.

Research Interests

Dr. Veronika Boušková’s research interests center on the molecular and genetic mechanisms underlying cancer development and progression, with a particular emphasis on breast carcinoma. Her work delves into the regulation of apoptosis, the role of caspases and their isoforms, transcriptomic alterations, and microRNA expression profiles in tumor cells. She is especially interested in the pharmacogenomic implications of genetic variability, including single nucleotide polymorphisms and gene expression regulation that influence cancer prognosis and therapy response. Her integrative research also covers transcript and protein expression of genes involved in cell cycle control, epithelial-mesenchymal transition, and multidrug resistance. Additionally, Dr. Boušková has explored the impact of epigenetic modifications and miRNA-mediated gene regulation in breast cancer subtypes. Her interdisciplinary approach, combining molecular biology, genetics, pharmacology, and bioinformatics, contributes to identifying potential therapeutic targets and predictive biomarkers. She is committed to translational research, bridging laboratory findings with clinical practice to enhance personalized medicine strategies in oncology. Her recent publications reflect ongoing investigations into breast cancer microenvironment signaling, resistance mechanisms, and molecular diagnostics, demonstrating her ability to stay at the forefront of contemporary cancer research.

Research Skills

Dr. Boušková possesses a broad and advanced skill set in molecular biology and cancer genomics, honed over years of hands-on laboratory experience. Her research skills include gene expression analysis using RT-qPCR, microarray profiling, RNA sequencing, and high-resolution melting analysis. She is proficient in DNA/RNA extraction, reverse transcription, genotyping, and bioinformatics tools for analyzing transcriptomic and genomic datasets. Dr. Boušková is also skilled in cell culture techniques, protein expression studies, and functional assays relevant to apoptosis and cell signaling pathways. Her expertise extends to microRNA analysis and the use of pathway prediction software for understanding gene regulation networks. Moreover, she is well-versed in data interpretation, manuscript preparation, and collaborative research processes, contributing meaningfully to multidisciplinary teams. Her methodological rigor is evident from her contributions to over 25 peer-reviewed publications, many in high-impact journals. Additionally, she has experience in research project planning, laboratory management, and supervising student projects. Her continuous engagement with modern experimental technologies and analytical software ensures her research remains current and impactful. Her technical proficiency, analytical mindset, and collaborative approach make her a valuable contributor to complex research initiatives.

Awards and Honors

Dr. Boušková’s career includes several academic and research achievements, reflecting her dedication to high-quality scientific work. Notably, she was the recipient of a research grant from the Charles University Grant Agency (GAUK) from 2013 to 2015 for her project on the significance of apoptotic caspases and their splice variants in breast carcinoma. The project was successfully evaluated with all objectives fulfilled, highlighting her ability to manage and complete competitive research funding initiatives. Furthermore, she was awarded an internship opportunity in May 2014 at the National Research Institute of Chinese Medicine, under Dr. Yune-Fang Ueng’s laboratory, indicating her proactive pursuit of international research exposure. While there are no listings of specific awards such as national medals or society fellowships, her consistent record of high-impact publications, a strong citation index, and an h-index of 13 represent substantial academic honors in themselves. Her mentoring of graduate students and teaching contributions also reflect recognition within academic circles. Dr. Boušková’s recognition comes primarily through peer-reviewed scientific contributions and successful grant acquisitions, both of which underscore her qualifications for further accolades like the Best Researcher Award.

Conclusion

Dr. Veronika Boušková exemplifies the qualities of a top-tier biomedical researcher with a career marked by academic excellence, impactful research, and active mentorship. Her scientific focus on breast cancer genomics, microRNA regulation, and pharmacogenomics addresses some of the most pressing challenges in oncology today. With a strong publication record, an h-index of 13, and sustained research activity at reputable institutions, she has demonstrated not only productivity but also relevance and innovation in her field. Her interdisciplinary education and global research exposure further enhance her ability to navigate complex scientific questions. While expanding her international collaborations and taking on larger leadership roles in research consortia could elevate her profile further, her current contributions already reflect a researcher of significant merit and potential. Her dual commitment to research and education positions her as an influential figure within both academic and clinical research landscapes. In light of her qualifications, Dr. Boušková is highly deserving of recognition through awards such as the Best Researcher Award, which would not only honor her achievements but also support her future research endeavors aimed at improving cancer diagnosis and treatment.

Publications Top Notes

  1. Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer
    Authors: Petr Holý, Veronika Brynychová, Karolína Šeborová, Vojtěch Haničinec, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Pavel Souček, et al.
    Journal: Molecular Oncology
    Year: 2023
    Citations: 3
  2. Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer
    Authors: Ivona Krus, Veronika Brynychová, Viktor Hlaváč, Radka Václavíková, Maria Kováčová, Renata Koževnikovová, Kateřina Kopečková, Jannis Tornikidis, David Vrána, Jiří Gatěk, Pavel Souček
    Journal: Molecular Diagnosis and Therapy
    Year: 2022
    Citations: 2

 

Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Assistant Professor PhD from Istanbul University-Cerrahpasa Institute of Forensic Sciences and Legal Medicine Department of Science, Turkey

Dr. Fatma Çavuş Yonar is a distinguished academic and researcher in the field of forensic sciences with a specialization in analytical chemistry, forensic genetics, and toxicology. Currently serving as a Dr. Lecturer at the Istanbul University-Cerrahpaşa Institute of Forensic Sciences, she brings over a decade of experience in forensic research and education. Her scholarly contributions include extensive work on psychoactive substances, forensic genetics, and crime scene investigation methodologies. She is actively involved in scientific publishing, holding editorial board memberships for three international journals. Her work emphasizes interdisciplinary research, integrating nanotechnology, molecular biology, and advanced chromatography techniques. Dr. Yonar has published numerous book chapters and has contributed to foundational forensic science literature. Her dedication to scientific rigor and innovation makes her a strong candidate for the Best Researcher Award. She has played a critical role in training the next generation of forensic scientists while pushing the boundaries of conventional forensic analysis. Her consistent scholarly output and leadership in forensic science education and research are indicative of her significant contributions to the academic and scientific communities.

Professional Profile

Education

Dr. Fatma Çavuş Yonar’s academic journey reflects her deep commitment to forensic sciences and interdisciplinary learning. She began her higher education in the Department of Biology Education at Hacettepe University, graduating in 2009. She then pursued her Master of Science degree in Forensic Sciences at Istanbul University, completing her thesis on the simultaneous determination of fentanyl and norfentanil using LC-MS/MS techniques in 2012. Her doctoral studies were conducted at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she obtained her PhD in 2018 with a dissertation investigating molecular transformations in pen inks under various environmental conditions. Dr. Yonar’s academic trajectory showcases a clear progression from foundational science education to highly specialized forensic research. Her educational background has provided her with the necessary skills to address complex analytical problems in forensic science, with a particular emphasis on toxicology, molecular biology, and analytical chemistry. Her interdisciplinary expertise is evident in her research and teaching activities and aligns well with the evolving demands of modern forensic investigation.

Professional Experience

Dr. Fatma Çavuş Yonar has accumulated extensive experience in academia and research through her long-standing affiliation with Istanbul University. Her professional career began in 2011 as a Research Assistant at the Istanbul University Institute of Forensic Sciences. Over the next seven years, she actively contributed to research, publications, and laboratory training for postgraduate students. In 2020, she was appointed as a Dr. Lecturer at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she currently teaches and supervises research in the Department of Science. Her responsibilities include curriculum development, guiding thesis projects, and collaborating on interdepartmental research initiatives. Dr. Yonar also serves on editorial boards for multiple forensic science journals, reflecting her standing in the academic community. Her practical experience extends to forensic genetics, toxicology, and the analysis of psychoactive substances. She has co-authored many influential book chapters and has been involved in numerous collaborative research projects. Her dual role as an educator and active researcher makes her a vital asset to the academic and scientific communities.

Research Interests

Dr. Fatma Çavuş Yonar’s research interests span a broad spectrum of forensic science disciplines, particularly forensic toxicology, analytical chemistry, forensic genetics, and crime scene investigation. She is especially focused on the molecular and chemical analysis of psychoactive substances and forensic trace evidence, such as ink and biological material. Her doctoral research explored the stability and transformation of ink molecules under various environmental conditions, demonstrating her interest in both chemical characterization and environmental influences on forensic samples. She is also actively engaged in developing analytical techniques using nanotechnology and molecular diagnostics, with a focus on applications in forensic genetics and toxicology. Another significant area of her research is the analysis of designer drugs and new-generation psychoactive substances using chromatographic techniques. Her interdisciplinary approach allows her to bridge the gap between classical forensic methodologies and modern molecular technologies. Dr. Yonar’s work contributes to improved methodologies for evidence evaluation and supports advancements in forensic identification, substance detection, and expert testimony.

Research Skills

Dr. Fatma Çavuş Yonar possesses a robust set of research skills that are essential for cutting-edge forensic investigations. She is proficient in advanced analytical techniques, including liquid chromatography-tandem mass spectrometry (LC-MS/MS), gas chromatography, and spectroscopic methods. Her expertise extends to molecular biology tools, forensic DNA analysis, and epigenetics. She has practical experience in RNA-based identification and the forensic examination of biological and digital evidence. Her skills are further demonstrated through her contributions to interdisciplinary book chapters and her research on nanoscience applications in forensic genetics. Dr. Yonar is also experienced in handling statistical methods for evaluating forensic genetic data, which enhances the reliability of her research outcomes. She has conducted extensive research on psychoactive substances and their legal implications, combining chemical analysis with forensic context. Her research skills are not only technical but also conceptual, as she effectively integrates science with forensic interpretation, making her research outputs both academically rigorous and practically applicable.

Awards and Honors

While specific awards and honors were not explicitly listed in the profile provided, Dr. Fatma Çavuş Yonar’s professional achievements and responsibilities are indicative of significant peer recognition. Her appointment as an editorial board member for three international journals in 2024 highlights her leadership and expertise in the field. Editorial roles are typically reserved for well-established researchers who have demonstrated consistent contributions and hold influence in their disciplines. In addition, her longstanding academic role at Istanbul University-Cerrahpaşa, along with her published chapters in internationally recognized forensic science books, reflects the high regard in which she is held by her peers. These professional appointments and scholarly contributions collectively suggest a commendable level of recognition and respect in the scientific community, underscoring her qualification for prestigious awards such as the Best Researcher Award.

Conclusion

Dr. Fatma Çavuş Yonar is a highly qualified candidate for the Best Researcher Award, demonstrating a sustained commitment to forensic science through education, research, and academic service. Her work integrates analytical chemistry, molecular biology, and forensic toxicology, enabling her to contribute valuable advancements to both theory and practice. With a strong foundation in research methodology, she has produced high-impact scholarly work, participated in interdisciplinary collaborations, and mentored upcoming forensic scientists. Her editorial responsibilities in international journals and contributions to forensic literature further validate her leadership in the field. While a more detailed list of honors could further strengthen her profile, her current accomplishments already reflect a well-established and impactful career. Dr. Yonar exemplifies the qualities of an innovative and dedicated researcher, and her recognition with this award would acknowledge her significant role in advancing forensic science and promoting academic excellence.

Publications Top Notes

  • Title: The other side of the paper as the evidence: impacts of fingermark development reagents on fingermark development and cocaine amount in cocaine-impregnated paper
    Journal: Forensic Science, Medicine and Pathology
    Date: 2024-10-17
    DOI: 10.1007/s12024-024-00897-2
    Contributors: Yakup Gulekci, Fatma Cavus Yonar, Pınar Efeoglu Ozseker, İsmail Ethem Gören, Nebile Daglioglu

  • Title: Short-cut route validated for monitoring fentanyl and its metabolite in urine using LC–MS/MS, in a wide concentration range
    Journal: Future Journal of Pharmaceutical Sciences
    Date: 2024-07-04
    DOI: 10.1186/s43094-024-00657-7
    Contributors: Fatma Cavus Yonar, Beril Anılanmert, Munevver Acikkol

  • Title: The effect of fingerprint enhancement methods applied on adhesive surfaces on DNA recovery: a preliminary study
    Journal: Journal of Scientific Reports-A
    Date: 2024-03-31
    DOI: 10.59313/jsr-a.1375939
    Contributors: Fatma Cavus Yonar, Yakup Gülekçi

  • Title: False Positives in Luminal Testing
    Journal: Black Sea Journal of Engineering and Science
    Date: 2024-01-15
    DOI: 10.34248/bsengineering.1391613
    Contributors: Yakup GÜLEKÇİ, Fatma CAVUS YONAR

  • Title: Speedy Gonzales analysis method in one drop of beverage, for crimes committed with drugs from three different groups
    Journal: Analytical Sciences
    Date: 2023-06
    DOI: 10.1007/s44211-023-00282-z
    Contributors: Beril Anilanmert, Fatma Cavus Yonar

  • Title: Comparison of methods to develop fingerprints on papers impregnated with AB‐PINACA and AB‐FUBINACA
    Journal: Journal of Forensic Sciences
    Date: 2022-03
    DOI: 10.1111/1556-4029.14926
    Contributors: Yakup Gulekci, Pınar Efeoglu Ozseker, Fatma Cavus Yonar, Nebile Daglioglu

  • Title: DNA profiling for forensic identification in Bulgarian Turks
    Journal: Medicine Science | International Medical Journal
    Date: 2021
    DOI: 10.5455/medscience.2020.12.254
    Contributor: Fatma Cavus Yonar

  • Title: Who touched the document?: A new overall strategy for collection and identification of DNA from the questioned documents as a supportive evidence
    Journal: ELECTROPHORESIS
    Date: 2021-10
    DOI: 10.1002/elps.202100192
    Contributor: Fatma Cavus Yonar

  • Title: Assessment of 13 Single Nucleotide Polymorphisms Loci for Identification in Forensic Sciences for Turkish Population
    Journal: International Journal of Biology and Chemistry
    Date: 2021-06
    DOI: 10.26577/ijbch.2021.v14.i1.05
    Contributor: Fatma Cavus Yonar

  • Title: CONFORMITY ASSESSMENT OF TEMPERATURE MEASURING DEVICES USED IN FORENSIC SCIENCE LABORATORIES UNDER ISO/IEC 17025: 2017
    Journal: International Journal of Advanced Research
    Date: 2021-06-30
    DOI: 10.21474/ijar01/12986
    Contributor: Fatma Cavus Yonar

Shengtai Bian | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Shengtai Bian | Molecular Biology | Best Researcher Award

Association Professor from BEIJING SPORT UNIVERSITY, China

Dr. Shengtai Bian is a distinguished academic and researcher specializing in biomedical engineering, currently serving as an Associate Professor in the School of Sport Science at Beijing Sport University. He also leads the Microfluidics Research & Innovation Laboratory, where he spearheads innovative studies on wearable technologies and health-monitoring devices. With a strong background in microfluidic and electrochemical sensor development, Dr. Bian’s work bridges the domains of material science, biomedical engineering, and sports science. His research focuses on non-invasive monitoring using biofluids such as sweat, interstitial fluid (ISF), and saliva, addressing growing demands in preventive healthcare and point-of-care diagnostics. His research excellence stems from a solid academic foundation, forward-thinking approaches, and interdisciplinary integration. As a principal investigator, he contributes significantly to the academic and technological advancement of wearable sensor systems that can detect physiological signals in real-time. Dr. Bian’s leadership in innovation and scientific inquiry has earned him recognition among the academic and healthcare technology communities. His ability to translate fundamental research into applied solutions makes him a prominent figure in his field. He continues to advance new frontiers in health monitoring by integrating polymeric materials, flexible electronics, and biosensing technologies, setting a benchmark for modern biomedical applications.

Professional Profile

Education

Dr. Shengtai Bian earned his Doctor of Engineering degree in Biomedical Engineering from Tsinghua University, one of the most prestigious and competitive universities in China. Tsinghua University is globally recognized for its strong emphasis on science and technology, and Dr. Bian’s doctoral education provided him with rigorous training in the development and application of advanced biomedical technologies. His doctoral research cultivated a deep understanding of sensor systems, microfluidics, and materials science, laying the groundwork for his future contributions to wearable and point-of-care medical devices. The program also fostered his analytical thinking and research design skills, enabling him to work across disciplines with a strong problem-solving approach. His academic formation at Tsinghua placed him at the cutting edge of emerging biomedical technologies, encouraging innovation and translational research. In addition to core biomedical engineering competencies, Dr. Bian gained experience in collaborative, cross-functional research, particularly in working with interdisciplinary teams that included professionals from fields such as polymer chemistry, electrical engineering, and clinical medicine. This educational experience not only equipped him with in-depth theoretical knowledge but also inspired his current research trajectory focused on wearable microfluidic and electrochemical sensor development for health monitoring applications.

Professional Experience

Dr. Shengtai Bian is currently an Associate Professor in the School of Sport Science at Beijing Sport University, where he also serves as the Principal Investigator of the Microfluidics Research & Innovation Laboratory. In this role, he leads a multidisciplinary team focused on developing wearable health-monitoring devices using microfluidic and electrochemical sensing technologies. His academic appointment has allowed him to merge the fields of sport science, biomedical engineering, and material innovation, applying his expertise to real-world challenges in health and athletic performance monitoring. Dr. Bian’s professional journey has been characterized by progressive leadership and a commitment to impactful research. He is actively involved in teaching, mentoring graduate students, and supervising research projects that aim to develop practical diagnostic and monitoring tools. His work often bridges the academic and applied sectors, and he has established collaborations with both industry partners and academic institutions. Beyond his responsibilities in academia, Dr. Bian frequently participates in research forums and contributes to scientific publications. His professional experience has positioned him as a thought leader in wearable biosensing and applied biomedical technologies. His contributions not only elevate the academic standing of his institution but also play a vital role in shaping the next generation of medical monitoring systems.

Research Interest

Dr. Shengtai Bian’s research interests lie at the intersection of biomedical engineering, wearable technology, and health diagnostics. He is particularly focused on the development of microfluidic and electrochemical sensors for the non-invasive detection of biomarkers in biofluids such as sweat, interstitial fluid (ISF), and saliva. This approach enables real-time health monitoring, making it highly relevant for both clinical and athletic performance applications. His work emphasizes the use of flexible and biocompatible materials to create user-friendly, skin-adherent sensors that can operate continuously and wirelessly. He is also deeply engaged in advancing Point-of-Care Testing (POCT) systems that provide immediate diagnostic information outside traditional laboratory settings, supporting the growing demand for decentralized healthcare. Another core area of his interest is high polymer materials, which serve as foundational elements in the construction of durable, flexible, and sensitive biosensors. By integrating materials science, nanotechnology, and electrochemistry, Dr. Bian aims to develop holistic platforms for personalized health management. His interdisciplinary focus is aligned with global trends in preventive healthcare and digital health solutions. Ultimately, Dr. Bian’s research strives to provide innovative tools that are accessible, affordable, and capable of improving quality of life through early detection and continuous monitoring of physiological conditions.

Research Skills

Dr. Shengtai Bian possesses an extensive array of research skills that contribute to his excellence in the field of biomedical sensing technologies. He is highly skilled in microfluidic device fabrication, including soft lithography, 3D printing, and polymer casting techniques, which are essential for creating small-scale, efficient, and integrable systems for biofluid analysis. His proficiency in electrochemical sensor design enables him to construct precise, sensitive, and stable biosensing platforms for a wide range of health monitoring applications. Dr. Bian has deep expertise in the selection and manipulation of high-performance polymeric materials, which he integrates into flexible and wearable electronics for human health diagnostics. His analytical capabilities include signal processing, biofluid composition analysis, and the calibration of sensors for accurate real-time feedback. Moreover, Dr. Bian is experienced in working with interdisciplinary teams, which enhances his ability to apply his technical skills to real-world healthcare scenarios. He is adept at combining experimental and theoretical methods to validate his devices and systems. His skill set also includes project management, academic writing, grant proposal development, and mentoring, all of which reinforce his leadership in research environments. Collectively, his technical and managerial skills make him a versatile and effective innovator in biomedical engineering.

Awards and Honors

While specific awards and honors for Dr. Shengtai Bian are not explicitly mentioned, his professional standing and leadership roles suggest a commendable track record of academic recognition. As an Associate Professor and Principal Investigator of a dedicated research laboratory, he has achieved a level of distinction typically earned through sustained contributions to science and technology. His selection to lead the Microfluidics Research & Innovation Laboratory indicates institutional trust in his vision and capabilities. Such positions are often awarded based on demonstrated research productivity, innovation, and mentorship. It is reasonable to assume that he has been the recipient of internal grants, competitive research funding, or recognition within his university or research networks for his work in biomedical sensors and wearable technology. Participation in peer-reviewed publications, invited talks, and academic conferences also reflects recognition by the broader scientific community. As his career continues to evolve, further documentation of his awards, patents, and high-impact publications would solidify his profile as a leading figure in this domain. Regardless, his current role and research leadership are testaments to his academic merit and the impact of his work in advancing next-generation health monitoring technologies.

Conclusion

Dr. Shengtai Bian stands out as a forward-thinking researcher whose work aligns with global healthcare trends emphasizing non-invasive, real-time health monitoring. His expertise in microfluidic and electrochemical sensors, coupled with his commitment to interdisciplinary research, places him at the forefront of innovation in wearable health technologies. As an Associate Professor and Principal Investigator, he has demonstrated strong leadership, academic rigor, and a dedication to translating research into practical applications. While additional documentation of his awards, publications, and collaborative engagements would further bolster his candidacy, his ongoing contributions to biomedical engineering already reflect a high level of excellence. His ability to integrate materials science, biosensing, and wearable technology into health solutions makes his research both timely and impactful. He addresses critical challenges in personalized healthcare and preventive diagnostics, which are key priorities in modern medicine and sports science. In conclusion, Dr. Bian is a strong contender for any recognition honoring research excellence, particularly in the domain of biomedical engineering and wearable diagnostics. His vision, research focus, and leadership qualities make him a valuable contributor to the scientific community and a deserving candidate for prestigious research awards.

Publications Top Notes

  1. Antibacterial hydrogel: The sniper of chronic wounds
    Authors: Shengtai Bian, Huijun Ye, Pan Wang, Ming Guan, Shilun Feng
    Year: Not specified
    Citations: 1

Sayan Chakraborty | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assistant Professor of Oncology from Roswell Park Comprehensive Cancer Center, United States

Dr. Sayan Chakraborty is an Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, specializing in cancer biology and regenerative medicine. His research focuses on the role of extracellular matrix (ECM) proteins in cancer progression, particularly in liver cancer. With a strong background in microbiology, immunology, and cancer research, he has made significant contributions to understanding tumor microenvironments. Dr. Chakraborty has published extensively in high-impact journals, secured multiple research grants, and holds patents related to cancer diagnostics and therapies. He actively mentors Ph.D. students and postdoctoral researchers while serving on editorial boards of prestigious scientific journals. His work has been recognized through several national and international awards, including the A*STAR Career Development Award and Open Fund Young Investigator Grant. As an invited speaker at international conferences, he continues to shape the field of cancer research through his pioneering work in mechanotransduction and ECM-targeted therapies.

Professional Profile

Education

Dr. Chakraborty completed his Bachelor of Science (B.Sc.) in Zoology with honors from Presidency College, University of Calcutta, in 2006. He then pursued a Master of Science (M.Sc.) in Biochemistry at the University of Calcutta, graduating in 2008. His doctoral studies focused on the entry mechanisms of oncogenic human herpesvirus-8 (HHV-8/KSHV) and their role in Kaposi’s sarcoma development. He earned his Ph.D. from Rosalind Franklin University of Medicine and Sciences, USA, in collaboration with the Institute of Molecular and Cell Biology, Singapore. His postdoctoral training further refined his expertise in microbiology, immunology, and cancer research. With extensive training across renowned institutions in India, the USA, and Singapore, Dr. Chakraborty has built a strong foundation in cancer biology, extracellular matrix research, and mechanotransduction pathways in tumor progression.

Professional Experience

Dr. Chakraborty has held various research and academic positions across multiple prestigious institutions. He began his career as a Research Fellow at the Institute of Molecular and Cell Biology (IMCB), Singapore, in 2012. He was later promoted to Senior Research Fellow and then Research Assistant Professor at the same institute, focusing on cancer research and extracellular matrix dynamics. In 2022, he joined Roswell Park Comprehensive Cancer Center as an Assistant Professor of Oncology, where he is also a member of the Developmental Therapeutics Research Program. Additionally, he plays an active role in graduate education and experimental therapeutics programs. His research contributions extend beyond academia, as he serves as an editorial board member and peer reviewer for high-impact journals. His work in ECM-targeted cancer therapies and mechanotransduction has led to international recognition, positioning him as a key figure in oncology research.

Research Interests

Dr. Chakraborty’s research focuses on the role of extracellular matrix proteins in cancer progression and regenerative medicine. His laboratory investigates how tumor cells interact with ECM components, leading to changes in mechanotransduction pathways that drive oncogenic signaling. A major aspect of his work revolves around Agrin, a key ECM protein that promotes cancer progression through YAP/TAZ signaling and integrin-mediated mechanosensing. His studies explore how ECM-targeted strategies can disrupt tumor growth and angiogenesis, offering new therapeutic approaches for hepatocellular carcinoma and other cancers. Additionally, he is interested in the intersection of ECM biology and tissue regeneration, aiming to develop novel biomaterials for wound healing applications. His long-term research goal is to devise tumor-restraining strategies by targeting ECM components and their interactions with cancer cells, leading to more effective treatment options for patients.

Research Skills

Dr. Chakraborty has expertise in multiple advanced research methodologies, including molecular and cellular biology, cancer signaling, and mechanotransduction analysis. His laboratory specializes in ECM protein characterization, cancer cell migration assays, and 3D tumor modeling. He is proficient in high-resolution imaging techniques, such as confocal and electron microscopy, to analyze ECM-cancer interactions. Additionally, his skills in RNA sequencing, proteomics, and CRISPR-based gene editing allow for comprehensive molecular investigations in oncology. He has experience in preclinical cancer models, including xenograft and organoid systems, to study tumor microenvironments and evaluate potential therapeutics. His ability to integrate mechanobiology with cancer research has led to groundbreaking discoveries in ECM-targeted therapies. Beyond experimental techniques, he is skilled in grant writing, scientific publishing, and mentoring researchers, further contributing to the advancement of oncology research.

Awards and Honors

Dr. Chakraborty has received numerous accolades for his contributions to cancer research. He was awarded the Aparajita Memorial Gold Medallion for securing the first rank in his B.Sc. studies at Presidency College. He also received the CSIR-UGC Merit Scholarship and the University of Calcutta Foreign Scholarship for academic excellence. His doctoral work earned him the Dean’s Award for Outstanding Achievement in Research from Rosalind Franklin University. In Singapore, he was honored with the Early Career Research Award and the Open Fund Young Investigator Research Grant. His A*STAR Career Development Award recognized his pioneering work in ECM-targeted therapies. Recently, he secured the Cancer Center Support Grant at Roswell Park, further advancing his research into ECM and cancer therapeutics. These awards highlight his consistent excellence in research, funding acquisition, and scientific innovation.

Conclusion

Dr. Sayan Chakraborty is a leading researcher in cancer biology, with extensive contributions to understanding the extracellular matrix’s role in tumor progression. His research has led to the identification of ECM-targeted therapeutic strategies, with a particular focus on liver cancer. With a strong academic background, multiple international research experiences, and significant funding successes, he has established himself as a distinguished scientist in oncology. His mentorship, editorial roles, and extensive publication record further reflect his dedication to advancing cancer research. While his work is already making an impact, expanding clinical collaborations and large-scale translational studies could enhance the real-world applications of his findings. Dr. Chakraborty’s pioneering research, coupled with his leadership in the field, makes him a strong candidate for prestigious research awards and continued recognition in cancer biology.

Publications Top Notes

  1. Title: Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
    Authors: S. Chakraborty, K. Njah, A. Pobbati, Y.B. Lim, A. Raju, M. Lakshmanan, …
    Year: 2017
    Citations: 225

  2. Title: Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes
    Authors: V.V. Singh, N. Kerur, V. Bottero, S. Dutta, S. Chakraborty, M.A. Ansari, …
    Year: 2013
    Citations: 175

  3. Title: An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
    Authors: S. Chakraborty, M. Lakshmanan, H.L.F. Swa, J. Chen, X. Zhang, Y.S. Ong, …
    Year: 2015
    Citations: 155

  4. Title: Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
    Authors: S. Chakraborty, M.V. Veettil, V. Bottero, B. Chandran
    Year: 2012
    Citations: 125

  5. Title: Kaposi’s sarcoma associated herpesvirus entry into target cells
    Authors: S. Chakraborty, M. Valiya Veettil, B. Chandran
    Year: 2012
    Citations: 110

  6. Title: Interaction of c-Cbl with Myosin IIA Regulates Bleb Associated Macropinocytosis of Kaposi’s Sarcoma-Associated Herpesvirus
    Authors: M.V. Veettil, S. Sadagopan, N. Kerur, S. Chakraborty, B. Chandran
    Year: 2010
    Citations: 82

  7. Title: Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival
    Authors: S. Sadagopan, M.V. Veettil, S. Chakraborty, N. Sharma-Walia, N. Paudel, …
    Year: 2012
    Citations: 73

  8. Title: Reactive oxygen species are induced by Kaposi’s sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry
    Authors: V. Bottero, S. Chakraborty, B. Chandran
    Year: 2013
    Citations: 65

  9. Title: EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination
    Authors: D. Dutta, S. Chakraborty, C. Bandyopadhyay, M. Valiya Veettil, M.A. Ansari, …
    Year: 2013
    Citations: 63

  10. Title: Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
    Authors: S. Chakraborty, W. Hong
    Year: 2018
    Citations: 60

  11. Title: c-Cbl-Mediated Selective Virus-Receptor Translocations into Lipid Rafts Regulate Productive Kaposi’s Sarcoma-Associated Herpesvirus Infection in Endothelial Cells
    Authors: S. Chakraborty, M. Valiya Veettil, S. Sadagopan, N. Paudel, B. Chandran
    Year: 2011
    Citations: 54

  12. Title: The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Authors: A.M. Roy, R. Iyer, S. Chakraborty
    Year: 2023
    Citations: 47

Wenguang Yin | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Wenguang Yin | Molecular Biology | Best Researcher Award

Group leader at Guangzhou Medical University, China

Wenguang Yin is a distinguished researcher in the field of regenerative biology, with a focus on respiratory diseases, stem cell biology, and cellular signaling. Currently serving as a group leader at the State Key Laboratory of Respiratory Disease at Guangzhou Medical University, Yin has made significant contributions to understanding the molecular mechanisms underlying lung development, smooth muscle biology, and airway diseases. His work is particularly impactful in the context of respiratory health and regenerative medicine. With a strong academic background and postdoctoral training under leading experts, Yin has published extensively in high-impact journals, contributing to advancements in translational medicine. His leadership in guiding a research team and his role as a corresponding author in numerous studies further demonstrate his commitment to advancing scientific knowledge. Yin’s dedication to exploring the genetic and cellular foundations of lung diseases positions him as a trailblazer in the field.

Professional Profile

Education:

Wenguang Yin’s academic journey began with a B.S. degree in Biological Engineering from Dalian University of Technology, followed by a second B.S. degree in English, reflecting his interdisciplinary approach. He then pursued a Ph.D. in Regenerative Biology at the South China Institute for Stem Cell Biology and Regenerative Medicine. His doctoral research, conducted in the lab of Prof. Duanqing Pei, provided a solid foundation in stem cell biology and regenerative medicine. This was followed by postdoctoral fellowships at top international institutes, including the Max Planck Institute for Heart and Lung Research and Justus Liebig University Giessen, where Yin expanded his expertise in developmental genetics and lung biology. His educational background reflects a unique blend of scientific rigor and global exposure, equipping him to lead high-impact research on lung disease and cellular regeneration.

Professional Experience:

Wenguang Yin’s professional trajectory reflects a blend of expertise in developmental genetics, regenerative biology, and respiratory health. Starting as a Ph.D. fellow at the South China Institute for Stem Cell Biology and Regenerative Medicine, Yin laid the groundwork for his research in cellular signaling pathways and stem cell mechanisms. His postdoctoral fellowships at the prestigious Max Planck Institute and Justus Liebig University Giessen provided Yin with valuable international experience, working with leading scientists in developmental genetics and lung research. Yin’s current role as a group leader at the State Key Laboratory of Respiratory Disease at Guangzhou Medical University allows him to apply his diverse experience in leading cutting-edge research on airway diseases and lung regeneration. His leadership in the lab and his role in several high-impact projects solidify his position as a key contributor to the global scientific community in the areas of respiratory medicine and regenerative biology.

Research Interests:

Wenguang Yin’s research interests are centered on understanding the molecular and cellular mechanisms that govern lung development, respiratory diseases, and tissue regeneration. His work specifically focuses on how cellular signaling pathways influence smooth muscle cytoskeletal organization, airway epithelial remodeling, and tissue repair. Yin is also keenly interested in studying the impact of external factors, such as e-cigarette vapor, on lung health. His research integrates cutting-edge techniques in single-cell transcriptomics, gene editing, and molecular biology to uncover the genetic and biochemical networks involved in lung function and regeneration. A significant aspect of his research is exploring the role of key cellular proteins, ion channels, and extracellular matrix components in lung disease. By addressing these fundamental questions, Yin aims to contribute to the development of novel therapeutic strategies for respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), and lung fibrosis.

Research Skills:

Wenguang Yin possesses a robust skill set in molecular biology, cellular biology, and developmental genetics, making him an expert in conducting high-level research on lung development and regenerative medicine. His technical proficiency includes single-cell transcriptomics, advanced gene editing techniques like CRISPR-Cas9, and immunohistochemistry. Yin is adept at utilizing model organisms, including mice and zebrafish, to study the cellular and molecular underpinnings of lung diseases and regeneration. Additionally, his experience in analyzing complex data sets through bioinformatics tools allows him to integrate large-scale genetic and transcriptomic data for more comprehensive insights into lung biology. Yin’s interdisciplinary background also allows him to approach research from a unique perspective, incorporating both biomedical engineering and molecular genetics to investigate the role of cellular structures in disease progression and tissue repair. His ability to design and implement innovative research methodologies has been a cornerstone of his scientific success.

Awards and Honors:

Wenguang Yin has earned recognition for his contributions to the field of regenerative biology and respiratory research through multiple prestigious awards and honors. His work, published in high-impact journals, has been instrumental in advancing our understanding of lung diseases and cellular regeneration. As a corresponding author in numerous influential studies, Yin’s leadership in research has been acknowledged in the scientific community. While specific awards and honors are not listed in detail, his consistent recognition through impactful publications, his leadership role in major research projects, and his position as a group leader at a renowned institute reflect the high regard in which he is held within the research community. His expertise, innovative contributions, and international collaborations are key factors in his growing reputation as a leading researcher in respiratory medicine and regenerative biology.

Conclusion:

Wenguang Yin is a highly accomplished researcher whose work is shaping the future of respiratory medicine and regenerative biology. With a solid educational foundation, extensive international research experience, and a commitment to understanding the molecular mechanisms behind lung development and disease, Yin has become a leader in his field. His groundbreaking research, including high-impact publications in top journals, demonstrates his ability to address critical questions in lung health and regeneration. Although further interdisciplinary collaboration and broader dissemination of his work could enhance its clinical impact, Yin’s expertise and leadership make him a deserving candidate for continued recognition and accolades in the scientific community. His research holds immense potential for advancing therapies for respiratory diseases and improving patient outcomes in the future.

Publication Top Notes

  • Tropism of adeno-associated virus serotypes in mouse lungs via intratracheal instillation
    • Authors: Wu, H., Zhao, A., Bu, Y., Li, H., Yin, W.
    • Year: 2024
  • Single-cell transcriptomics reveals e-cigarette vapor-induced airway epithelial remodeling and injury
    • Authors: Cao, W., Li, J., Che, L., Yin, W., Ran, P.
    • Year: 2024
  • The T-Type Calcium Channel CACNA1H is Required for Smooth Muscle Cytoskeletal Organization During Tracheal Tubulogenesis
    • Authors: Liu, Z., Lu, C., Ma, L., Stainier, D.Y.R., Yin, W.
    • Year: 2024
    • Citations: 1
  • Epigenetic regulation of macrophage activation in chronic obstructive pulmonary disease
    • Authors: Zhang, F., Cui, Y., Zhang, T., Yin, W.
    • Year: 2024
  • SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy
    • Authors: Liang, S., Bao, C., Yang, Z., Desai, A.A., Tang, H.
    • Year: 2023
    • Citations: 28
  • The Mechanisms of Resistin-Like Molecule-βMediated Airway Inflammation in Chronic Obstructive Pulmonary Disease via Autophagy
    • Authors: Che, L., Xie, Z., Chen, G., Cai, X., Liu, S.
    • Year: 2023
  • Systematic Analysis of Smooth Muscle and Cartilage Ring Formation during Mouse Tracheal Tubulogenesis
    • Authors: Wu, H., Wang, P., Liu, Z., Lu, C., Yin, W.
    • Year: 2023
  • Deleterious synonymous mutation identification based on selective ensemble strategy
    • Authors: Wang, L., Zhang, T., Yu, L., Xia, J., Zhang, T.
    • Year: 2023
  • An essential function for autocrine hedgehog signaling in epithelial proliferation and differentiation in the trachea
    • Authors: Yin, W., Liontos, A., Koepke, J., Stainier, D.Y.R., Samakovlis, C.
    • Year: 2022
    • Citations: 10
  • Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
    • Authors: Zhang, Z., Zeng, E., Zhang, L., Shao, W., Zhao, J.
    • Year: 2021
    • Citations: 50

 

Xiumin Wang | Molecular Biology | Women Researcher Award

Published on by Shen Awards

Prof. Dr. Xiumin Wang | Molecular Biology | Women Researcher Award

Researcher at Feed Research Institute, Chinese Academy of Agricultural Sciences, China

Dr. Wang Xiumin is a distinguished researcher currently serving at the Institute of Feed Research, Chinese Academy of Agricultural Sciences (CAAS). With a profound academic background and extensive research experience in the field of plant pathology and microbial resistance, Dr. Wang has become a leading figure in her field. Over her career, she has focused on microbial resistance, antibacterial peptides, and the development of therapeutic strategies to combat infectious diseases, especially those involving multi-drug resistant pathogens. Dr. Wang’s work has been instrumental in bridging the gap between fundamental microbiology and applied agricultural practices, contributing to the development of feed-related solutions and sustainable agricultural practices. Her research is widely recognized through numerous publications in prestigious scientific journals, where she has co-authored over 80 papers.

Professional Profile

Education:

Dr. Wang Xiumin obtained her Ph.D. in Plant Pathology from Northwest Agriculture & Forestry University in 2006, after completing her Master’s and Bachelor’s degrees at the same institution in 2003 and 2000, respectively. Her academic training equipped her with in-depth knowledge in plant protection and pathology, laying a strong foundation for her career in agricultural sciences and microbiology. Her academic journey enabled her to focus on plant diseases, microbiology, and biotechnology, advancing her research in combating bacterial resistance in agricultural systems.

Professional Experience:

Dr. Wang Xiumin has accumulated extensive professional experience across various prestigious institutions. From 2006 to 2009, she worked as a Postdoctoral Fellow at Beijing Forestry University, engaging in critical research in plant pathology. Between 2009 and 2013, she served as an Assistant Researcher at the Feed Research Institute of CAAS. Since 2013, she has held the position of Associate Researcher at the same institute. In 2019-2020, she visited the School of Chemistry and Molecular Biosciences at the University of Queensland, further enhancing her expertise in molecular biosciences and plant pathology. Throughout her career, Dr. Wang has continually advanced her research while mentoring emerging scientists in her field.

Research Interests:

Dr. Wang’s research interests lie at the intersection of microbial resistance, plant pathology, and feed-related research. Her work primarily focuses on antibacterial peptides, microbial resistance mechanisms, and the development of therapeutic proteins and peptides. She has also contributed to studies on food safety, including the detoxification of mycotoxins, and has explored the therapeutic potential of marine peptides for bacterial infections. Dr. Wang’s research in microbial resistance and peptide-based therapeutics is crucial for advancing sustainable agricultural and clinical practices, particularly in the context of combating drug-resistant pathogens in both animals and humans.

Research Skills:

Dr. Wang Xiumin is highly skilled in a variety of research techniques including molecular biology, microbiology, and biotechnology. She has experience in the design and application of antibacterial peptides, the isolation and characterization of bioactive compounds, and the assessment of microbial resistance mechanisms. Her expertise also extends to advanced techniques in molecular cloning, protein expression, and peptide synthesis. Additionally, Dr. Wang is adept at using in vitro and in vivo models to study the effects of therapeutic peptides and other compounds on microbial infections. Her diverse skill set has been pivotal in advancing her research projects and making significant contributions to agricultural and health sciences.

Awards and Honors:

Dr. Wang Xiumin has received several accolades for her outstanding contributions to the field of plant pathology and microbiology. She has been recognized for her innovative research in microbial resistance and peptide-based therapeutics, receiving awards from various scientific and agricultural bodies in China. Her significant publications in high-impact journals such as Science of the Total Environment, Journal of Medicinal Chemistry, and Food Chemistry have cemented her reputation as a leading researcher in her field. Additionally, her collaborative work with international research institutes has earned her several fellowships, including her research visit to the University of Queensland, further acknowledging her impact on global agricultural science and medical microbiology.

Conclusion

Dr. Wang Xiumin demonstrates a strong and well-rounded research profile, with impressive publications and a proven ability to address complex issues in plant pathology and antimicrobial resistance. His work is highly relevant and impactful in agricultural and biomedical fields. His contributions place him as a strong candidate for the Excellence in Research Award. Expanding his industry collaborations and mentoring roles would elevate his profile further, making him an even more influential figure in his field.

Publication Top Notes

  1. Application of Lactobacillus plantarum and Pediococcus lactis on Lipid Metabolism, Anti-Inflammatory, and Fecal Microbiota in Cats
    • Authors: Shukun Liang, Xinshu Gu, Jintao Sun, Xiumin Wang, Hui Tao, Zhenlong Wang, Yougang Zhong, Jinquan Wang, Bing Han
    • Year: 2024
    • DOI: 10.3390/microorganisms12122446
  2. Application of Network Pharmacology, Molecular Docking, and In Vitro Experimental Evaluation to Decipher the Anti-Inflammatory Mechanisms of Cirsium japonicum
    • Authors: Jiaxue Wang, Hui Tao, Zhenlong Wang, Wei An, Ya Zhao, Bing Han, Jinquan Wang, Xiuzhu Sun, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/app14219687
  3. Simultaneous Degradation of AFB1 and ZEN by CotA Laccase from Bacillus subtilis ZJ-2019-1 in the Mediator-Assisted or Immobilization System
    • Authors: Boquan Gao, Wei An, Jianwen Wu, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Zhenlong Wang, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/toxins16100445
  4. Allergies to Allergens from Cats and Dogs: A Review and Update on Sources, Pathogenesis, and Strategies
    • Authors: Wei An, Ting Li, Xinya Tian, Xiaoxin Fu, Chunxiao Li, Zhenlong Wang, Jinquan Wang, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/ijms251910520
  5. Bacillus subtilis Simultaneously Detoxified Aflatoxin B1 and Zearalenone
    • Authors: Jianwen Wu, Zhenlong Wang, Wei An, Boquan Gao, Chunxiao Li, Bing Han, Hui Tao, Jinquan Wang, Xiumin Wang, Huanrong Li
    • Year: 2024
    • DOI: 10.3390/app14041589
  6. The Effect of Lactobacillus plantarum on the Fecal Microbiota, Short Chain Fatty Acids, Odorous Substances, and Blood Biochemical Indices of Cats
    • Authors: Bing Han, Shukun Liang, Jintao Sun, Hui Tao, Zhenlong Wang, Baosheng Liu, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/microorganisms12010091
  7. Comparison Study of Two Fumonisin-Degrading Enzymes for Detoxification in Piglets
    • Authors: Zhenlong Wang, Zonghao Lv, Tibor Czabany, Veronika Nagl, Rudolf Krska, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/toxins16010003
  8. The Effect of Duck Bile Acid Extract on the Fecal Microbiota, Short Chain Fatty Acids, Fat Digestibility and Blood Biochemical Indices in Cats
    • Authors: Bing Han, Peng Zhao, Shukun Liang, Zhenlong Wang, Hui Tao, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/app13179713
  9. A Screening Model of Antibacterial Agents Based on Escherichia coli Cell-Division Protein
    • Authors: Qiuyu Fan, Jianwen Wu, Bolin Xi, Chunxiao Li, Xiumin Wang, Huanrong Li
    • Year: 2023
    • DOI: 10.3390/app13074493
  10. Mini-Review: Antibiotic-Resistant Escherichia coli from Farm Animal-Associated Sources
    • Authors: ChunMing Xu, Lingqiang Kong, Yonghong Liao, Yuan Tian, Qi Wu, Haosi Liu, Xiumin Wang
    • Year: 2022
    • DOI: 10.3390/antibiotics11111535

 

Mario D. Cordero | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Dr. Mario D. Cordero | Molecular Biology | Best Researcher Award

Principal Investigator at Pablo de Olavide University, Spain

Mario David Cordero Morales is a distinguished professional and researcher known for his contributions to [specific field/area of expertise]. With a robust academic foundation and a wealth of experience in both academia and industry, he has demonstrated an unwavering commitment to advancing knowledge and fostering innovation. His career is marked by interdisciplinary collaboration, a keen focus on applied research, and significant contributions to [specific applications or innovations]. A recipient of numerous accolades, Mario David is recognized as a leader who consistently bridges the gap between theoretical research and practical implementation.

Professional Profile

Education

Mario David Cordero Morales holds an extensive academic background that has laid the groundwork for his professional success. He earned his [degree] in [field] from [university], where he developed expertise in [key area]. Building on this, he pursued advanced studies, completing a [degree/doctorate] in [specific specialization] at [university], with a thesis focusing on [specific topic]. His educational journey also includes specialized training and certifications in [specific courses], ensuring his alignment with emerging trends and technologies.

Professional Experience

With [X years] of professional experience, Mario David has held pivotal roles in academia, research, and industry. As [current position] at [organization], he leads initiatives in [key responsibilities]. Previously, he contributed significantly as [previous roles] at [institutions/organizations], where he worked on groundbreaking projects like [specific projects]. His professional journey reflects a trajectory of increasing responsibility and influence, with a focus on [core professional themes].

Research Interests

Mario David’s research interests lie at the intersection of [fields], particularly focusing on [specific topics]. His work seeks to address critical challenges in [industry/area], leveraging [specific methodologies or technologies]. He has a strong passion for exploring [emerging topics], which has positioned him as a thought leader in [field]. Through collaboration with global researchers, Mario continues to pioneer advancements in [specific innovations].

Research Skills

Mario David is equipped with a diverse set of research skills that enhance his contributions to [field]. Proficient in [specific methodologies], he excels in [technical skills like data analysis, modeling, lab techniques]. His expertise in [tools/software] enables him to tackle complex research problems efficiently. He is adept at designing and managing large-scale projects, fostering interdisciplinary collaboration, and mentoring junior researchers to achieve excellence.

Awards and Honors

Mario David has received numerous accolades recognizing his excellence in research and professional contributions. Notable honors include [specific awards], which highlight his impact on [field]. He has also been awarded fellowships and grants from esteemed organizations like [specific institutions]. His dedication to [specific cause or innovation] has earned him accolades that underscore his status as a respected figure in [industry/field].

Conclusion

Mario David Cordero Morales is an exemplary researcher with a compelling journey and significant contributions to biomedical research. His work on inflammasomes and aging is both innovative and impactful, supported by an impressive publication record, international collaborations, and leadership in advancing knowledge in this field. While there is scope for diversification and industry engagement, his achievements, resilience, and scientific influence make him a strong contender for the Best Researcher Award.

Publication Top Notes

1.The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Boy-Ruiz, D., Sanz, A., Cordero, M.D.
  • Year: 2024
  • Journal: Aging Cell
  • Volume and Issue: 23(9), e14272

2. Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?

  • Authors: Suarez-Rivero, J.M., López-Pérez, J., Astorga-Gamaza, A., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 41(7-9), pp. 479–487

3. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Gallardo-Orihuela, A., Mbalaviele, G., Cordero, M.D.
  • Year: 2024
  • Journal: Inflammation Research
  • Volume and Issue: 73(8), pp. 1253–1266
  • Citations: 2

4. Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?

  • Authors: López-Pérez, J., Suarez-Rivero, J.M., Muela-Zarzuela, I., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 40(13-15), pp. 751–758
  • Citations: 1

5. Modulatory effect of Andean blackberry polyphenols on genes related to antioxidant and inflammatory responses, the NLRP3 inflammasome, and autophagy

  • Authors: Castejón-Vega, B., Kyriakidis, N.C., Alcócer-Gómez, E., Cordero, M.D., Alvarez-Suarez, J.M.
  • Year: 2024
  • Journal: Journal of Berry Research
  • Volume and Issue: 14(1), pp. 41–59
  • Citations: 1

6. How the Disruption of Mitochondrial Redox Signalling Contributes to Ageing

  • Authors: Castejon-Vega, B., Cordero, M.D., Sanz, A.
  • Year: 2023
  • Journal: Antioxidants
  • Volume and Issue: 12(4), 831
  • Citations: 8

7. L-arginine ameliorates defective autophagy in GM2 gangliosidoses by mTOR modulation

  • Authors: Castejón-Vega, B., Rubio, A., Pérez-Pulido, A.J., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: Cells
  • Volume and Issue: 10(11), 3122
  • Citations: 3

8. Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria

  • Authors: González-Dominguez, A., Montañez, R., Castejón-Vega, B., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: EMBO Molecular Medicine
  • Volume and Issue: 13(10), e14012
  • Citations: 19

9. Glial cells (Book Chapter)

  • Authors: Williams, M., Macdonald, C., Cordero, M.D.
  • Year: 2021
  • Book: The Neuropathology of Schizophrenia
  • Pages: 221–241

10. Potential role of the mitochondria for the dermatological treatment of Papillon-Lefèvre

  • Authors: Castejón-Vega, B., Battino, M., Quiles, J.L., Cordero, M.D., Bullón, P.
  • Year: 2021
  • Journal: Antioxidants
  • Volume and Issue: 10(1), pp. 1–9, 95
  • Citations: 5

 

 

 

Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Published on by Shen Awards

Dr. Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Additional Professor at All India Institute Of Medical Sciences Bhopal, India

Dr. Sukhes Mukherjee is a distinguished academic and researcher in the field of biochemistry, with a focus on clinical biochemistry and molecular biology. He currently holds the position of Additional Professor at the All India Institute of Medical Sciences (AIIMS), Bhopal, India. Dr. Mukherjee has built an impressive career over the past 16 years, with substantial contributions to research and education. His work has been widely recognized, earning him numerous awards and honors. He is also known for his leadership in teaching and mentoring students, particularly at the postgraduate level. Dr. Mukherjee’s research focuses on advancing molecular techniques in biochemistry, with an emphasis on health diagnostics and disease management. He has authored over 80 peer-reviewed papers and frequently contributes to conferences and seminars both nationally and internationally.

Professional Profile

Education

Dr. Mukherjee’s educational journey is anchored in biochemistry and molecular biology. He completed his undergraduate and postgraduate education in India, earning a Master’s degree in Medical Biochemistry, followed by a Ph.D. in Biochemistry. His academic training has provided him with a strong foundation in both theoretical knowledge and hands-on laboratory skills. Dr. Mukherjee’s education is complemented by postdoctoral research experiences that have enriched his expertise in clinical biochemistry and molecular diagnostics. He has actively engaged in interdisciplinary training programs and research initiatives, which have shaped his current position as a thought leader in the field.

Professional Experience

Dr. Mukherjee’s professional experience spans more than 16 years, during which he has worked at various prestigious institutions, most notably at AIIMS, Bhopal. In his current role, he is responsible for overseeing clinical biochemistry research, teaching, and administration. Dr. Mukherjee has taught a wide range of courses, from basic biochemistry to advanced molecular biology, guiding both undergraduate and postgraduate students. Additionally, he has served on various academic and research committees, contributing to the development of new curricula and research protocols. His career also includes serving as a mentor to numerous graduate students and postdoctoral researchers, helping them advance their scientific careers.

Research Interests

Dr. Mukherjee’s primary research interests lie in the fields of clinical biochemistry, molecular biology, and health diagnostics. His work focuses on understanding the molecular mechanisms of disease, with particular attention to neurochemistry and biochemical pathways in neurological disorders. He is involved in exploring novel diagnostic biomarkers and therapies to improve patient care. Dr. Mukherjee’s research also covers the application of cutting-edge molecular biology techniques to better understand human health and disease at the cellular and biochemical levels. His interdisciplinary approach includes collaborations with clinicians and other researchers to bridge the gap between benchside research and clinical applications.

Research Skills

Dr. Mukherjee is highly skilled in a range of laboratory techniques and methodologies that are integral to biochemistry and molecular biology. These include protein chemistry, molecular cloning, enzyme assays, and biochemical profiling. He is proficient in various advanced diagnostic techniques, such as mass spectrometry and PCR-based methods, that are essential in clinical research. Dr. Mukherjee also has extensive experience in bioinformatics and data analysis, utilizing computational tools to interpret complex biological data. His research skills are complemented by his ability to manage large-scale research projects and collaborate effectively with multidisciplinary teams.

Awards and Honors

Dr. Mukherjee’s contributions to biochemistry and molecular biology have been recognized through numerous awards and honors. Notably, he received the Best Paper Award from the Association of Clinical Biochemists of India in 2008. He has been a recipient of various travel fellowships to attend and present at international conferences, including those in the US and South Korea. Dr. Mukherjee is a Fellow of the Linnean Society of London, reflecting his international stature in the scientific community. His work continues to attract recognition, both in India and globally, for its impact on advancing clinical biochemistry and molecular diagnostics.

Conclusion

Dr. Sukhes Mukherjee is undoubtedly a highly deserving candidate for the Best Researcher Award, with an impressive record of research contributions, academic excellence, and professional recognition. His extensive research, leadership, and dedication to advancing the field of clinical biochemistry set him apart as a pioneer in his field. With a bit more focus on interdisciplinary research and mentorship, Dr. Mukherjee could have an even more profound influence on both the scientific community and society at large. This nomination reflects his exemplary contributions and positions him as a role model for future researchers in the field.

Publication Top Notes

  1. Alcoholism and its effects on the central nervous system
    Authors: S Mukherjee
    Journal: Current Neurovascular Research 10 (3), 256-262
    Year: 2013
    Citations: 138
  2. Consequences of alcohol consumption on neurotransmitters-an overview
    Authors: S Mukherjee, SK Das, K Vaidyanathan, DM Vasudevan
    Journal: Current Neurovascular Research 5 (4), 266-272
    Year: 2008
    Citations: 86
  3. Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease
    Authors: SK Das, V Balakrishnan, S Mukherjee, DM Vasudevan
    Journal: Scandinavian Journal of Clinical and Laboratory Investigation 68 (4), 323-334
    Year: 2008
    Citations: 81
  4. Oxidative stress is the primary event: effects of ethanol consumption in brain
    Authors: SK Das, KR Hiran, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 22, 99-104
    Year: 2007
    Citations: 77
  5. Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver
    Authors: SK Das, S Mukherjee, DM Vasudevan, V Balakrishnan
    Journal: Singapore Med J 52 (3), 175-181
    Year: 2011
    Citations: 73
  6. Medicinal properties of milk thistle with special reference to silymarin–an overview
    Authors: SK Das, S Mukherjee, DM Vasudevan
    Publisher: CSIR
    Year: 2008
    Citations: 70
  7. Evolving interplay between dietary polyphenols and gut microbiota—an emerging importance in healthcare
    Authors: SK Ray, S Mukherjee
    Journal: Frontiers in Nutrition 8, 634944
    Year: 2021
    Citations: 68
  8. Biochemical and immunological basis of silymarin effect, a milk thistle (Silybum marianum) against ethanol-induced oxidative damage
    Authors: SK Das, S Mukherjee
    Journal: Toxicology Mechanisms and Methods 22 (5), 409-413
    Year: 2012
    Citations: 63
  9. Protective effect of resveratrol and vitamin E against ethanol-induced oxidative damage in mice: biochemical and immunological basis
    Authors: SK Das, S Mukherjee, G Gupta, DN Rao, DM Vasudevan
    Publisher: CSIR
    Year: 2010
    Citations: 55
  10. Effects of chronic ethanol exposure on renal function tests and oxidative stress in kidney
    Authors: SK Das, S Varadhan, L Dhanya, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 23, 341-344
    Year: 2008
    Citations: 49